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Background: Human T-cell leukemia virus type 1 (HTLV-I) is a human retrovirus associated with adult T-cell
leukemia (ATL), an aggressive CD4 T-cell proliferative disease with dismal prognosis. The long latency preceding the
development of the disease and the low incidence suggests that the virus itself is not sufficient for transformation
and that genetic defects are required to create a permissive environment for leukemia. In fact, ATL cells are
characterized by profound genetic modifications including structural and numerical chromosome alterations.
Results: In this study we used molecular combing techniques to study the effect of the oncoprotein Tax on DNA
replication. We found that replication forks have difficulties replicating complex DNA, fork progression is slower, and
they pause or stall more frequently in the presence of Tax expression. Our results also show that Tax-associated
replication defects are partially compensated by an increase in the firing of back-up origins. Consistent with these
effects of Tax on DNA replication, an increase in double strand DNA breaks (DDSB) was seen in Tax expressing cells.
Tax-mediated increases in DDSBs were associated with the ability of Tax to activate NF-kB and to stimulate
intracellular nitric oxide production. We also demonstrated a reduced expression of human translesion synthesis
(TLS) DNA polymerases Pol-H and Pol-K in HTLV-I-transformed T cells and ATL cells. This was associated with an
increase in DNA breaks induced by Tax at specific genome regions, such as the c-Myc and the Bcl-2 major
breakpoints. Consistent with the notion that the non-homologous end joining (NHEJ) pathway is hyperactive in
HTLV-I-transformed cells, we found that inhibition of the NHEJ pathway induces significant killing of HTLV-I
transformed cells and patient-derived leukemic ATL cells.
Conclusion: Our results suggest that, replication problems increase genetic instability in HTLV-I-transformed cells.
As a result, abuse of NHEJ and a defective homologous repair (HR) DNA repair pathway can be targeted as a new
therapeutic approach for the treatment of adult T-cell leukemia.Introduction
During DNA synthesis, replication forks repeatedly
come across obstacles that impede their progression.
Arrested forks are very unstable and have to be restarted
promptly in order to prevent the formation of DDSB
and genome instability [1-3]. In normal cells, a few
DDSB foci can be observed during replication of DNA
in the S phase. These breaks are generally quickly
repaired and the cell proceeds with division. Some* Correspondence: cnicot@kumc.edu
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article, unless otherwise stated.oncogenes increase the rate of replication fork stalling,
which facilitates chromosome rearrangement at com-
mon fragile sites in precancerous lesions and increases
the transformation rate [4]. Other oncogenes increase
the formation of DDSBs or interfere with the DNA re-
pair machinery to promote transformation. DDSBs are
the most dangerous form of DNA damage, because if in-
correctly repaired, they cause problems for transcription,
replication, and chromosome segregation [5-7].
HTLV-I-associated ATL has very limited therapeutic
options and the projected 4-year survival rates for acute-
and lymphoma-type ATL patients stand at 5 and 5.7%,
respectively [8,9]. Development of the disease usuallyentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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sion of viral genes can be detected and viremia is absent.
Infected cells evade host immune clearance through the
combined action of p12 and p30 [10]. Persistence and ex-
pansion of the provirus mostly occurs by cellular division
leading to clonal expansion of infected cells [11]. In con-
trast to other onco-retroviruses, HTLV-I controls its own
latency by expressing the p30 viral protein [12,13]. In-
terestingly, this characteristic is not shared by HTLV-II
[13]. The viral Tax protein has oncogenic properties and
can immortalize human primary T cells [14], transform fi-
broblasts [15], and lead to various tumors in transgenic
mouse models [16-19]. Numerous studies have demon-
strated that Tax alters cell cycle checkpoints, prevents
apoptosis, and inhibits DNA repair pathways [20-25]. In
addition, Tax favors long term proliferation and survival of
infected cells by stimulating telomerase expression
[26,27]. During the in vivo expansion of ATL cells, the ex-
pression of Tax progressively decreases and is compen-
sated by accumulated mutations in cellular genes and
constitutive activation of signaling pathways. We have pre-
viously shown that HTLV-I transformed cells have a
higher than normal basal level of phosphorylated ATM
(S1981) and p-H2AX, suggesting continuous formation of
DDSBs [28]. Dual staining for γ-H2AX and BrDU in-
corporation, which marks DNA breaks in S phase, de-
monstrated that γ-H2AX foci were mostly detected in
Tax-expressing cells with replicating DNA [29]. These
findings were further confirmed by staining for γ-H2AX
and Cyclin A, a marker of cells in S phase. The cells that
stained positive for γ-H2AX were also positive for Cyclin
A. Finally, similar results were also obtained with γ-H2AX
and PCNA (Proliferating cell nuclear antigen), for which a
punctuated signal is indicative of cells in S phase. These
studies reveal a mutagenic activity associated with Tax ex-
pression. Moreover, we have recently demonstrated that
Tax inhibited the HR repair pathway, thereby creating a
“mutator phenotype” [29]. However, how Tax increases
DDSBs during DNA replication and the biological con-
sequences of the Tax-induced DDSBs remain largely
unknown.
In this study we use molecular combing techniques to
study the effect of HTLV-I Tax on DNA replication. We
use cells that constitutively express Tax as well as cells
stably transfected with an inducible Tax expression vec-
tor to check for potential cell adaptation. Our results
demonstrate that replication forks are generally slower
and stall more often in cells expressing Tax. The cellular
response to Tax expression translated into an increase in
the firing of back-up origins of replication. These obser-
vations are consistent with the notion that dormant rep-
lication origins fire in response to replication issues and
generally lead to an increase in DDSBs. Our results also
demonstrate that Tax does not directly provoke DNAbreaks but rather that these DDSBs result from the
faulty activation of the HR pathway, which is inhi-
bited by Tax. We further demonstrate that in HTLV-I-
transformed and Tax-expressing cells the expression of
TLS DNA polymerases Pol-H and Pol-K are significantly
reduced, further adding stress on replication of com-
plex DNA structures and stalled replication forks. We
demonstrate that the expression of chemoresistant genes
Pol-H and Pol-K is down-regulated in HTLV-I- and
ATL-transformed cells. Importantly, we also found that
Tax expression increases DNA breaks associated with
non-B-DNA conformation chromatin at the c-Myc pro-
moter and the Bcl-2 major break point. Finally, in-
hibition of the NHEJ DNA repair pathway by NU7026
induces significant cell death of HTLV-I-transformed
and patient leukemic cells, suggesting that drugs tar-
geting the NHEJ pathway might offer new therapeutic
options for patients with ATL.
Results
Replication forks are slower in the presence of the HTLV-I
Tax oncoprotein
The aim of this study is to investigate the effect of Tax on
DNA replication. To this end we utilized HTLV-I-
transformed MT4 cells (with constitutive expression of
Tax) and a Jurkat cell line (JPX9) that is stably transfected
with an inducible Tax-expressing vector (Figure 1A).
Induction of Tax expression in Jurkat cells was associated
with DDSBs and increased p-H2AX (Figure 1B). For
clarity, induced JPX9 cells will be labeled JPX9 Tax+ here-
after. Using molecular combing techniques, we first asked
whether expression of Tax leads to replication defects
(Figure 1C). JPX9, JPX9 Tax+, and MT4 cells were pulse-
labeled with two nucleotide analogs, IdU (5-iododeoxyuri-
dine) and CldU (5-chlorodeoxyuridine), which incorporate
into newly synthesized DNA. To visualize tracks of repli-
cation by DNA combing, IdU and CldU were revealed by
specific fluorescent markers, red and green, respectively
(Figure 1C and 1D). IdU (first pulse) is incorporated be-
fore CldU (second pulse) and allows us to determine the
direction of replication fork progression and the presence
of active replication origins.
Then we determined fork speed by measuring the
length of CldU tracks, only when they followed an IdU
track (Figure 1E and 1F). This allows us to focus only on
forks that are currently active when the cells received
the CldU. To obtain fork speed, the length of the track
was divided by the length of the pulse (15 min). Analysis
of multiple independent experiments revealed that the
distance covered by individual forks during the pulse
was significantly shorter and slower in the Tax-expres-
sing cells, JPX9 Tax + and MT4, when compared to JPX9
control cells (Figure 1F). We also showed that fork speed
was slower in Tax expressing cells, compared to non-Tax
Figure 1 (See legend on next page.)
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Figure 1 Replication forks are slower in the presence of the HTLV-I Tax oncoprotein. (A) HTLV-I Tax expression was confirmed after
induction with Cadmium chloride (CdCl) in Tax inducible Jurkat, JPX9 cells. (B). Induction of Tax expression was associated with an increase in
DNA breaks detected by FACS analyses of p-H2AX. (C) Schematic representation of a single molecule analysis of DNA replication by molecular
combing. (D) MT4, JPX9 and JPX9 Tax+ cells were pulse-labelled for 15 min with IdU then 15 min with CldU, and fibers were stretched by DNA
combing. Blue: DNA. Red: IdU. Green: CldU. An example of a fiber representative for each condition is shown. (E) Replication fork speed analysis.
The lengths of CldU tracks (ImageJ) were measured and divided by the length of the pulse (15 min). (F) Box and whisker plots: Box: 25–75
percentile range and Whiskers: 5–95 percentile range. More than 300 values coming from 3 independent experiments were compiled. Statistical
analysis was performed using the non-parametric Mann–Whitney rank sum test. ns: not significant. *: p < 0.05; **: p < 0.01; ****: p < 0.0001.
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duced Tax expression compared to constitutive Tax ex-
pression, presumably because following induction of Tax
expression, the cells are faced with replication problems
they do not usually encounter and to which they are not
adapted.
Tax impedes DNA replication fork progression
We next characterized fork progression in the different
conditions by determining the IdU/CldU ratio (Figure 2A).
This ratio allows us to determine whether replication
forks progress continuously or encounter obstacles that
can slow or stop them: in this latter case, the length of the
CldU track should be shorter than the IdU track, leading
to an increased ratio. We show that Tax-expressing cells
have a higher ratio than non-Tax-expressing cells, mea-
ning that, for each single replication fork, the more they
replicate DNA, the more problems they accumulate. TheFigure 2 Tax blocks DNA replication fork progression. (A-B) Box and w
range. More than 300 values coming from 3 independent experiments were
Mann–Whitney rank sum test. ns: not significant. *: p < 0.05; **: p < 0.01; ****:
replication forks, IdU/CldU ratio. (B): Analyses of the center-to-center distance
indicative of origin firing frequency.shorter labeled tracks observed in MT4 and JPX9 Tax
+-expressing cells compared to JPX9 cells could be due to
slower forks or to an increase in fork stalling. To discrim-
inate between these two possibilities, the progression of
sister replication forks was analyzed by DNA combing. In
normal cells, sister forks progressed at a similar rate from
a given origin and generated symmetrical patterns of
IdU/CldU incorporation. We analyzed the ratio of the
longest to the shortest IdU signals to reveal any increase
in fork asymmetry in Tax-expressing cells relative to con-
trols. Our results showed that sister forks did not progress
at a similar rate from a given origin and generated asym-
metrical patterns of IdU/CldU incorporation. Analysis of
the ratio of the longest to the shortest IdU signals for each
pair of sister replication forks also revealed an increase in
fork asymmetry. These results indicate that replication
forks are not only slower, but also pause and stall more
frequently in the presence of Tax expression. These resultshisker plots. Box: 25–75 percentile range. Whiskers: 5–95 percentile
compiled. Statistical analysis was performed using the non-parametric
p < 0.0001. (A): Measurement of acceleration and deceleration of
which reflects the distance between two replication origins and is
Table 2 Tax increases origin firing by activating back-up
origins







< 0,0001 < 0,0001 0,0297
Ratio IdU/CldU < 0,0001 < 0,0001 0,397
Distance
center-to-center
0,0442 < 0,0001 < 0,0001
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in progressing through complex DNA structures, which
may result in replication fork fallout. This is consistent
with our previously reported increased formation of
DDSBs observed in S phase in Tax expressing cells.
Tax increases origin firing by activating back-up origins
Since origins of replication are at the middle of IdU/CldU
incorporation signals, the initiation rate can be estimated
by center-to-center distances between tracks (Figure 2B).
Shorter distances are indicative of an increase in the
initiation rates or origin firing. We measured the center to
center distance (the distance between two tracks on the
same fiber), which reflects the distance between two repli-
cation origins and is indicative of origin firing frequency
(Figure 2B). Again, we show that this distance is different
between Tax expressing and non-expressing cells. Since
this distance is shorter in Tax expressing cells, these cells
have an increased initiation rate, by activating back-up ori-
gins. These data are consistent with other studies showing
that dormant replication origins fire in response to repli-
cation issues. Again, this phenotype is more prominent
following induced expression of Tax (JPX9 Tax+) as op-
posed to constitutive Tax expression (MT4). We think
that MT4 cells have adapted to constitutive expression of
Tax. Our data is in agreement with the previously reported
effects of Tax on the minichromosome maintenance com-
plex and increased origin firing [30]. Our results show that
Tax induction leads to multiple replication defects, partly
compensated by activation of back-up origins. A summary
of these data and statistically significant differences bet-
ween MT-4 and JPX-9, MT-4 and Jurkat and JPX9 and
Jurkat cells are summarized in Table 1 and Table 2.
Tax-mediated increases in NO production promote the
accumulation of DDSBs during DNA replication
Our previous data demonstrated that Tax-associated
DDSBs occur mainly during replication of DNA in the S
phase. Hence, it is difficult to assess whether these
DDSBs are induced directly by Tax or if they result from
replication-associated breaks and accumulate as a result
of inefficient HR-mediated repair when Tax is present.
We reason that if we express Tax in a cell line already
deficient in HR repair, we will then be able to assess the
importance of replication-associated breaks indepen-
dently of HR. Reports suggest that BRCA1-deficient
cells are largely deficient in the HR repair pathway [31].Table 1 Tax impedes DNA replication fork progression
Median value MT4 JPX9 JPX9 Tax
Replication speed on CldU tracks (kb/min) 0,78 1,46 0,60
Ratio IdU/CldU 1,02 0,63 0,97
Distance center-to-center (kb) 78,50 94,98 40,63Therefore, we used BRCA1−/− UWB1.289 cells (289
thereafter) and UWB1.289BRCA1, the counterpart cell
line reconstituted with BRCA1 expression to test our hy-
pothesis. We first confirmed reduced HR activity in 289
cells when compared to UWB1.289BRCA1 cells by using
a previously described HR-GFP reporter assays [32] and
FACS analyses. In this assay, the Sce1 restriction enzyme
induces a single cleavage site in the GFP vector. Upon
repair, a GFP signal is produced if the repair has oc-
curred through the HR repair pathway. Our results first
confirmed that 289 cells are indeed deficient in the HR
repair pathway as shown by a significantly decreased
GFP signal when compared to BRCA1-reconstituted
cells (Figure 3A). We hypothesized that if Tax is able to
induce breaks directly, independently from its inhibition
of HR, expression of Tax in 289 cells will be associated
with an increase in γ-H2AX. On the other hand, if
DDSBs associated with Tax expression are indirect, and
only the result of Tax-inhibition of HR during DNA
replication associated breaks, expression of Tax in
HR-deficient cells will not be associated with an increase
in DDSBs, as detected by γ-H2AX foci. Cells were trans-
duced with Tax-IRES GFP-expressing virus. The per-
centage of cells transduced was fairly equivalent for both
lines 289 and 289BRCA1 cell lines as evaluated by GFP
expression and FACS analyses (data not shown). We
then assessed the presence of DNA breaks in each cell
line in the absence of Tax or forty-eight hours after
transduction with Tax-IRES GFP-expressing vector. Our
results demonstrated an increase in p-H2AX between
289 and 289 BRCA1 cells (Figure 3B). These results sug-
gest that Tax does induce DDSBs independently from its
inhibitory effect of HR. Consistent with these results,
western blot assays revealed a significant increase in
p-H2AX only in 289 cells in the presence of Tax
(Figure 3C). Since previous studies have suggested that
Tax can increase the expression of iNOS in monocyte
U937 cells and nitric oxide (NO) has been linked to
DDSBs, we tested Tax and Tax mutants for their ability
to stimulate nitric oxide (NO) production. We used Tax
and Tax mutants able to stimulate either the NF-kB or
the CREB pathway, M47 and G148V, respectively. Our
results showed that both wild-type Tax and the Tax mu-
tant M47 can increase NO production while the Tax
Figure 3 Tax expression induces DDSBs by stimulating intracellular NO. HR activity (A) is reduced in 289 cells when compared to BRCA1
cells. Tax triggers H2AX phosphorylation in BRCA1-deficient cell. The 289 and BRCA1 cells were infected with GFP or Tax-IRES GFP-expressing virus
during 48 hours. 293T cells were transfected with 1.5 μg DR-GFP and 0.5 μg pSCE I expression vector or empty vector. The percentage of GFP+
cells was estimated by FACS. (B) Tax triggers H2AX phosphorylation in BRCA1-deficient cell. The 289 and BRCA1 cells were infected with GFP or
Tax-IRES GFP-expressing virus during 48 hours. The cells were analyzed (B) by Flow cytometry and (C) by western blot. (D-F) Tax and M47 Tax
mutant stimulate NO production and trigger H2AX phosphorylation. 293T cells were transfected with 2 μg of empty vector (Ø), Tax, or Tax
mutants (M47 and G148V). At 72 h, cell culture supernatant was harvested and tested for NO production (D), and cells were further analyzed by
FACS for ɣ-H2AX quantification (E) and by western blot for Tax expression (F). (G-I) The NOS inhibitor L-NMMA blocks NO production and DDSBs
induced by Tax. 293T cells were transfected with the empty vector (Ø), Tax, or Tax mutants (M47 and G148V) during 24 h and treated with DMSO
or 30 μM L-NMMA for 48 h. Cell culture supernatant was harvested and tested for NO production (G). Cells were analyzed by FACS for ɣ-H2AX
quantification (H) and western blot to confirm Tax expression (I).
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notion that NO has been shown to produce DNA breaks
at replication sites, expression of Tax and the Tax mu-
tant M47 were associated with DDSBs, as shown by an
increase in p-H2AX expression (Figure 3E). Expression
levels of Tax and Tax mutants were fairly equivalent
(Figure 3 F). Interestingly, the effect of Tax and Tax mu-
tants on DDSBs correlated with their ability to activate
the NF-kB pathway and to stimulate NO production in-
asmuch as Tax G148V was unable to produce NO and
did not create DDSBs. In addition to NF-kB, other path-
ways activated by Tax but not the M47 mutant may beresponsible for the lower NO activation seen in Figure 3D.
For instance Tax-mediated AP-1 activation is not shared
by the M47 mutant [33].To further demonstrate a direct
link between Tax-mediated NO production and the
formation of DDSBs, we treated Tax expressing cells
with a specific NO inhibitor, N-Monomethyl-L-arginin
(LNMMA). As expected, treatment with LNMMA greatly
reduced the ability of Tax to stimulate NO production
(Figure 3G). Consistent with our hypothesis, decreased
Tax-mediated NO production was associated with a de-
crease in DDSB formation (Figure 3H), while Tax expres-
sion was not affected (Figure 3I). Altogether our results
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sites by stimulating intracellular NO production and
impairing DNA replication forks.
Reduced expression of human translesion synthesis (TLS)
DNA polymerases in HTLV-I-transformed and
Tax-expressing cells
Cells are constantly exposed to DNA damaging agents.
Lesions induce activation of checkpoints and G1 arrest
to allow repair before the cells proceed to S phase and
DNA replication. Tax-expressing cells bear a high rate of
DDSBs and have multiple defects in cell cycle check-
points. When DNA lesions are not repaired before DNA
replication is initiated, it can block the replication ma-
chinery and lead to cell cycle arrest and apoptosis. To
bypass these blocks and proceed with DNA replication,
specialized translesion synthesis (TLS) DNA polyme-
rases of the γ-family are recruited and allow error-prone


































































































































Figure 4 Reduced expression of Pol-H (A) and Pol-K (B) in HTLV-1 cell
to GAPDH expression. Fold change was calculated by comparing values with
expression was demonstrated by RT-PCR. Tax protein expression was detectedTLSs in HTLV-I transformed cells has not been previ-
ously investigated. TLS expression is mainly controlled
by the tumor suppressor p53 and by p21WAF [35,36]. In
cells where p53 or p21WAF are inactivated, TLS expres-
sion is deregulated, leading to unrestrained mutagenic
bypass of DNA lesions, accumulation of mutations, and
increased drug resistance of cancer cells. In addition, a
loss in the expression of TLS’s Pol-H or Pol-K, ex-
pression also results in increased DDSBs and genome
instability. Our results showed a significant reduction
in the expression of Pol-H and Pol-K in HTLV-I-
transformed cells (Figure 4A and 4B). We also found
that both Tax-negative ATL-derived cell lines and Tax-
expressing ATL-derived cell lines had significantly re-
duced expression of Pol-K and Pol-H (Figure 4A, 4B
and 4C).
Although transient expression of Tax in Jurkat cells
was clearly associated with DNA breaks and increased














































































































































. Real-time PCR was performed in duplicate and samples were normalized
T cells (sorted from healthy donor) and/or Jurkat. (C) Viral tax mRNA
by immunoblots in HTLV-I-transformed cell lines in vitro.
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cible inhibitory effect of about 15% on Pol-K expression
(data not shown). In contrast, down regulation of Pol-H
and Pol-K was readily observed in the Tax-immortalized
primary T cell line, WT4 (Figure 4A and 4B). These re-
sults suggest that chronic expression of Tax may be
responsible for adaptation and reduced expression of
Pol-H and Pol-K in HTLV-I- and ATL-transformed cells
and warrants further studies.
Tax expression increases DNA breaks associated with
non-B-DNA conformation chromatin at the c-Myc
promoter and the Bcl-2 major break point
Endogenous sources of interference with replication fork
progression exist within complex DNA sequences. These
have the potential to adopt non-B-DNA conformations
and are abundant in chromosomal regions that are
prone to rearrangements, such as the major breakage
hotspots found in c-Myc or sequences that form G
quadruplex DNA. These DNA structures are phy-
siological substrates of both Pol-H and Pol-K, which are
required when replication forks are challenged by non-
B-DNA to facilitate replication fork reactivation and/or
avoid fork collapses and DDSB induction. Since loss of
Pol-H or Pol-K expression results in increased DDSBs,
down-regulation of these TLS DNA polymerases could
be a contributing factor in Tax-induced DNA breaks in
S phase. To study the effect of Tax expression on non-
B-DNA conformations, we constructed different cell
lines with stable integration of either a plasmid contain-
ing G-rich sequences from the human c-Myc promoter
region (pUMycProm) or a sequence from the human
Bcl-2 major break point region (pUMBR) into their gen-
ome (Figure 5A). As a control we also established a cell
line with stable integration of B-DNA sequence from the
GAPDH gene (pUCONT).
To investigate the effects of Tax on non-B-DNA struc-
tures, we generated high titer Tax-expressing virus
(HRCMVTax) to reach high efficiency of transduction.
pUMYC, pUMBR and pUCONT cell lines were infected
with HRCMVTax and analyzed after 48 hours for DNA
breaks by immuno-detection of p-H2AX and quantifica-
tion by FACS. Our results showed a reproducible in-
crease in DNA breaks of about 2.5 and 9% for pUMBR
and pUMYC (compared with and without Tax expres-
sion), respectively (Figure 5B). Such a percentage in-
crease in p-H2AX is consistent with previous studies
performed with siRNA knock-down of Pol-H and Pol-K
[37]. Interestingly, we found that the effect of Tax was
more pronounced at the c-Myc promoter, suggesting
that Tax may preferentially target particular genomic re-
gions. Sequencing analyses revealed internal deletions at
the c-Myc promoter in the presence of Tax in 8% of
clones tested (Figure 5C).NHEJ inhibition induces cell death in HTLV-I-transformed
and ATL cells
Our previous studies demonstrated that Ku80 and
DNA-PK specifically co-localized with γ-H2AX foci on
DNA breaks in Tax-expressing cells, while RAD51 foci,
a marker for HR repair, co-localized with γ-H2AX in
control cells but not in Tax-expressing cells. We further
demonstrated that in Tax-expressing cells, DDSBs are
repaired mostly in an HR-independent manner through
the activation of the NHEJ pathway. We hypothesized
that the faulty activation of the NHEJ repair pathway
during S phase may cause HTLV-I-transformed cells to
become resistant to chemotherapeutic agents. We then
tested the effect of NU7026, a specific DNA-PK and
NHEJ inhibitor. The use of NU7026 had a significant in-
hibitory effect on the proliferation of HTLV-I-transformed
MT4 cells as shown by XTT assays (Figure 6A). These
data are consistent with previous reports showing a
G2/M arrest after treatment with NU7026 and the
presence of a functional G2/M checkpoint in HTLV-I-
transformed cells.
We next tested a RAD 51 inhibitor of the HR repair
pathway, RI-1. RAD51 was found to be overexpressed in
many tumors and transformed cell lines and increased
RAD51 expression correlates with resistance to chemo-
therapies and radiotherapies [38]. Previous studies have
shown that RI-1 (20 μM) completely inhibited the for-
mation of DNA damage-induced RAD51 foci in immor-
talized human fibroblasts and more than 90% of HR
DNA repair [39]. Higher concentrations of RI-1 have
also been shown to inhibit single-strand annealing (SSA)
[39]. These observations may be important because SSA
repair efficiency is known to be increased when RAD51
functions are disrupted, which has been shown to be the
case for HTLV-I. It is important to evaluate which of the
DNA repair pathways are essential for survival of HTLV-
I-transformed cells, as this may allow rationale for the
design of effective combination therapies. Therefore, we
next investigated whether targeting the HR repair path-
way may be an additional approach for treatment of
HTLV-I-transformed cells. The use of RI-1, up to
20 μM, had no significant effect on either the prolifera-
tion or the killing of HTLV-I-transformed MT4 cells
(Figure 6C and 6D). Similar results were obtained using
other HTLV-I-transformed cells (data not shown). These
results may in part be explained by the fact that the HR
repair pathway is already inhibited in HTLV-I-
transformed cells [29] and these cells may have already
adapted. As a result of a deficient HR repair pathway,
HTLV-I-transformed cells are dependent on alternative
DNA repair pathways. Because of intrinsic genetic in-
stability and the presence of DDSB, identification of re-
pair pathways needed for ATL cells may be used as an
Achilles’ Heel for future therapies.
Figure 5 Tax expression increases DNA breaks and rearrangement in a human c-MYC promoter region rich in non-B-DNA forming
sequences. (A) Establishment of stable cell lines containing a non-DNA sequence control from the GAPDH gene (pULCtrl), a c-MYC promoter
region (pUMyc), and a BCL-2 gene major break region (pUMBR) as described in the Material and Methods. (B) pUCONT, pUMYC and pUMBR cell
lines were infected with HRCMV or HRCMVTax virus for 48 h and analyzed by Flow cytometry to quantify ɣ-H2AX. Scatter plots are represented
with ɣ-H2AX intensity on the y axis and propidium iodide intensity on the x axis. The cell populations used for the measurement of the
ɣ-H2AX-positive cells were enclosed by rectangles. (C) Tax induces a small scale deletion in the c-MYC promoter. After 48 h infection by HRCMV
or HRCMVTax, the genomic DNA was isolated from the pUMyc cells and subjected to PCR to amplify c-MYC promoter region. The PCR product
was cloned into pGEM-T Easy vector and the inserts were verified by DNA sequencing.
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Although the mechanism by which HTLV-I transforms
human T cells and triggers leukemia or lymphoma is not
fully understood, it is clear that Tax plays a central role
in this process. It is believed that Tax expression is
initially needed to transform T cells but its expression
may not be required to maintain the transformed pheno-
type, although this has not been formally demonstrated.
Tax inhibits pro-apoptotic pathways and reactivates
hTERT expression, thereby extending the lifespan and
replicative potential of virus-infected cells. Tax has also
been shown to target multiple G1/S cell cycle check-
points to enhance proliferation of HTLV-I leukemic
cells. Finally, Tax prematurely activates the anaphase
promoting complex [40], inhibits nucleotide excision
repair [41], and alters topoisomerases [42] and beta-polymerases [43], and the mini-chromosome main-
tenance, MCM2-7, helicase [30]. Consequently, Tax
expression is associated with increased genomic and
genetic instability.
We previously demonstrated that Tax expression is as-
sociated with an accumulation of DNA double strand
breaks during S phase and that Tax inhibits the HR
DNA repair pathway. In this study, we first investigated
the effects of Tax on DNA replication forks. We found
that Tax expression was associated with significantly
shorter DNA replication forks, which also paused and
stalled more often. These results suggest that Tax ex-
pressing cells have greater difficulties in replicating their
DNA and progressing through complex DNA structures,
which results in the accumulation of replication fork
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Figure 6 NU7026 inhibits growth and induces apoptosis in HTLV-I cell lines, but not RI-1. (A) MT4 cells were treated with increasing
concentrations of NU7026. After 3 days of treatment, cells were stained with XTT and measurements were quantified at OD: 450 nm. The results
represent the means of 2 separate experiments + SD. (B) MT4 cells were treated with NU7026 (10 μM). After 3 and 5 days of treatment, cells
were stained with Annexin V and PI, and analyzed by flow cytometry. (C) MT4 cells were treated with an increasing concentration of RI-1. After 3
days of treatment, cells were stained with XTT and measurements were quantified at OD: 450 nm. The results represent the means of 2 separate
experiments + SD. (D) MT4 cells were treated with RI-1 (20 μM). After 3 and 5 days of treatment, cells were stained with Annexin V and PI, and
analyzed by flow cytometry. (E) ATL cell lines were treated with NU7026 (10 μM) for 3 days. Then, cells were stained with XTT and measurements
were quantified at OD: 450 nm. The results represent the means of 2 separate experiments + SD.
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through activation of back-up origins in Tax-expressing
cells. While this could partially compensate for slower
progression of the replication fork, it can also sensitize
cells to accumulate additional DNA breaks.
Using BRCA1-deficient cells, deficient in the HR DNA
repair pathway, we further demonstrated that Tax dir-
ectly induces DNA breaks independently from its inhibi-
tory effects on HR. In fact, we demonstrate that Tax
expression stimulates NO production resulting in the
formation of DNA double strand breaks. Translesion
synthesis (TLS) DNA polymerases of the γ-family allow
error-prone replication through damaged DNA. Among
the TLS, Pol-H and Pol-K expression is mainly con-
trolled by p53 and p21waf. It is believed that both the
increase and decrease of Pol-K steady-state levels can
promote a malignant phenotype. In fact, the Pol-K genehas been shown to display loss of heterozygosity in
non-squamous lung carcinomas compared to adjacent
normal tissue [44]. Pol-K-knockout mice have been ge-
nerated and show increased spontaneous mutagenesis in
the kidney, liver, and lung [45,46]. Loss of Pol-H activity
has been associated with hyper mutability and a cancer-
prone syndrome known as xeroderma pigmentosum
variant (XPV) [47]. Expression of TLS has never been
evaluated in HTLV-I leukemic cells. Several studies have
demonstrated that Tax inactivates p53 transcriptional
functions through multiple pathways [48]. In addition,
Tax has also been demonstrated to alter p21waf expres-
sion and functions. We therefore tested expression of
Pol-H and Pol-K in HTLV-I-transformed cells, Tax-
immortalized T cells and ATL cells. Overall, our results
demonstrated a significant loss of both Pol-H and Pol-K
gene expression in HTLV-I-transformed cells. As a
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sions in HTLV-I-transformed cells may be compromised,
leading to an increase in replication fork stalling and an
increase in the drop off rate resulting in accumulation
of DDSB and chromosome instability. Interestingly,
attenuated expression of hMSH2 has been reported in
ATL patients [49]. Depletion of hMSH2 impairs PCNA
mono-ubiquitination and the formation of foci con-
taining Pol-K and other TLS polymerases at stalled rep-
lication fork sites after DNA damage [50].
In response to the excessive genomic instability present
in cancer cells, alterations in various DNA repair pathways
are selected in most aggressive tumor cells. Because we
have previously shown a shift from HR to the NHEJ DNA
repair in HTLV-I leukemic cells, we investigated whether
inhibition of either the NHEJ or HR repair pathway could
constitute an efficient therapeutic approach. Therapeutic
concentrations of the DNA-PK NHEJ inhibitor, NU7026,
were effective against all HTLV-I-transformed cells and
ATL cells tested, inducing a significant reduction in cell
proliferation, accompanied by cell death through apop-
tosis. In contrast, the use of a Rad51 HR inhibitor, RI-1
had no significant effect on HTLV-I-transformed cells
and ATL cells when used at concentrations sufficient
to inhibit the HR pathway. Some toxicity was observed
at higher concentrations but these effects may be re-
lated to inhibition of the SSA pathway or non-specific
off target effects.
In cancers that are deficient in the HR repair pathway,
the alternative DNA repair pathways are essential for cell
viability. In fact, Poly-ADP-ribose polymerase 1 (PARP1),
which plays a signaling role in the DNA Base Excision
Repair pathway (BER), is critical for viability of familial
breast cancer cells deficient in HR proteins BRCA1 and
BRCA2. As a result, these cells are sensitive to inhibitors
of PARP1. Taken together, our results suggest that iden-
tification of all alternative pathways used by HTLV-I-




DR-GFP and pSceI for the HR assay were provided by Dr.
M. Jasin. Wild-type Tax and the Tax mutants M47 and
G148V cDNA were subcloned in pCDNA3.1. pcDNA-Tax
expresses the wild-type Tax, G148V expresses a Tax mu-
tant that can activate CREB/ATF but not NF-kB, and M47
expresses a Tax mutant that can activate NF-kB but not
CREB/ATF.
In vivo HR DNA-repair assay
The DR-GFP reporter vector uses a modified gene
for green fluorescent protein (GFP) as a recombination
reporter and the I-Sce I endonuclease for theintroduction of DDSBs. The DR-GFP was transfected
into UWB1.289 and UWB1.289 + BRCA1 cells either
with the negative-control vector or with the Sce I-
expressing vector. Forty-eight hours after transfection,
cells were collected and GFP + cells were counted using
an LSR II flow cytometer (BD Biosciences).
Cell culture
The HTLV-I-transformed cell line expressing Tax, MT4,
and the Jurkat Tax-inducible JPX9 cells were cultured in
RPMI 1640 supplemented with 10% fetal calf serum
(RPMI-FCS). Expression of Tax was induced in JPX9
cells by addition of CdCl220 μM for 24 hours (referred
to as JPX9 Tax+ thereafter). The UWB1.289 cell line
was maintained in 50% RPMI + 50% MEGM,
supplemented with 3% fetal bovine serum, and
UWB1.289 + BRCA1 was maintained in the same
medium. The UWB1.289 + BRCA1 cell line was a gift
from Dr. Jensen (University of Kansas Medical Center).
Human 293T cells were maintained in continuous cul-
ture using Dulbecco’s modified Eagle medium (DMEM)
supplemented with 1% penicillin-streptomycin and 10%
fetal calf serum (FCS). ATL patient-derived cell lines
(KK1, KOB, ATL-55 T, SLB1, ATL-25, ATL-T, SO4 and
ATL-43 T) were cultured in RPMI1640 supplemented
with 20% FBS and IL-2. The ATL-derived cell line ED-
40515(−), referred to as ED, was cultured in RPMI1640
supplemented with 10% FBS.
Nitric oxide measurement
NO production from transfected cells was determined by
measuring nitrite levels in the supernatants. Nitric oxide
(NO) is rapidly oxidized to nitrite and nitrate, which can
be used to determine NO production. The nitric oxide
colorimetric assay kit (Biovision, USA) was used to mea-
sure the total nitrate/nitrite in the samples. The measure-
ments were carried out according to the manufacturer’s
protocol.
Establishment of chromosomal non-B-DNA forming
sequences 293T cell lines
The pULCtrl, pUMBR, pUMycProm plasmids [37] were
kindly provided by Dr. Karen M. Vasquez, University of
Texas M.D Anderson Cancer Center. pULCtrl has a
600 bp control non-B DNA sequence from the GAPDH
gene and is not known to form non-B DNA structure.
pUMycProm has 556 bp of the promoter region of the
human c-MYC gene containing 3 Z-DNA, one H-DNA
and one G-DNA forming regions. pUMBR has 520 bp
from the human BCL-2 gene major break region (MBR)
containing several H-DNA forming regions. The plas-
mids were digested with BsaI and 10 μg of each linea-
rized plasmid DNA was purified from agarose gel and
co-transfected with 1 μg of pSIH1-puro plasmid into
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selecting in medium containing 1 μg/ml puromycin
during 10 days. The plasmids harboring non-B-DNA
forming sequences contain a functional LacZ gene. To
check the integration of the plasmid fragments, the
genomic DNA of each transgenic cell line was isolated
and subjected to PCR to evaluate the presence of the
LacZ gene (F: 5′-CCAACTTAATCGCCTTGCGG-3′, R:
5′-GACGACAGTATCGGCCTCAG-3′) for the three
stable cell lines and the GAPDH gene (F: 5′-GGATG
CCTTTGTGGAACTGTACGG-3′, R 3′-ACAGGAAC
CCTCCCTCTGTTAATATC-5′) for the pULCtrl cell
line; the BCL-2-MBR gene (F 5′-GTCATGTGCATTTC
CACGTCAACA-3′, R 5′-GGATAGCAGCACAGGAT
TGGAT-3′) for the pUMBR cell line, and the c-MYC
promoter region (F 5′-ATGCGTTGCTGGGTTATT
TTAATCA-3′, R 5′-CGGAGATTAGCGAGAGAGGA
TC-3′) for the pUMycProm cell line.Real-time Quantitative PCR
Total RNA was extracted with TRIzol (Invitrogen), treated
with DNaseI (Roche-Applied Science) and reverse-tran-
scribed using the RNA-to-cDNA Kit (Invitrogen). cDNA
was used in real-time quantitative PCR using iTaq Univer-
sal SYBR Green Supermix (Bio-Rad) on the StepOnePlus
Real-Time PCR system. The following primers were
used: GAPDH-F: 5′- GAAGGTGAAGGTCGGAGTC-3′,





samples were normalized to GAPDH expression. Fold
change was calculated as the ratio of normalized expres-
sion of the target gene divided by the normalized expres-
sion of the control sample. T cells were obtained from a
healthy, non-HTLV-I-infected person.Western blotting
Inducible expression of HTLV-I Tax in JPX-9 and the
HTLV-I-transformed cell line MT4 was analyzed by
Western blotting assays. Cell extracts were prepared
using RIPA buffer (1% triton, 1% DOC, 1% NP40,
0.1% SDS, 0.15 M NaCl, 50 mM Tris (pH = 7.5) and
protease inhibitors were resolved by 10% SDS-PAGE
and transferred to a polyvinylidene difluoride (PVDF)
membrane. The blot was blocked with 5% milk in
PBS, and then incubated with anti-Tax antibody (NIH
AIDS Reagent Program, HTLV-I Tax Hybridoma
(168B17)). Reactive proteins were developed with se-
condary antibody conjugated to alkaline phosphatase
and visualized with super signal chemiluminescent
(Thermo Scientific).Lentivirus preparation and transduction of Tax to stable
cell lines
Semi-confluent 293T cells plated in 150 mm were trans-
fected with packaging plasmid pDNL6 (10 μg), HRCMV-
Tax-ires-GFP (20 μg) and pVSV-G (10 μg) using calcium
phosphate (Invitrogen) according to the manufacturer’s
instructions. Supernatant was collected at 24, 48 and
72 hours and virus particles were concentrated by ultra-
centrifugation. Concentrated virus was used to infect
stable cell lines and cells were analyzed 48 hours later.
ϒ-H2AX staining by flow cytometry
Forty-eight hours after infection with the concentrated
Tax virus, cells were harvested and fixed with 70% etha-
nol for 30 min, washed with PBS and permeabilized for
30 min in PBS FBS 2% Triton 0.1% (FACS buffer). Cells
were resuspended in a total volume of 100 μl containing
rabbit polyclonal anti-phospho-histone H2AX antibody
(Cell Signaling (#2753); 1/50 dilution) and incubated 1 h
under constant agitation at room temperature (RT).
Samples were rinsed twice with FACS buffer and resus-
pended in 100 μl with the secondary antibody Alexa 488
goat anti-rabbit IgG (H + L) conjugate (molecular probes
(#A11008), 1/200) for 1 h under constant agitation at
RT. Samples were washed twice with FACS buffer and
resuspended in PBS containing 50 μg/ml Propidium
Iodide (SIGMA (P4170)) and 100 μg/ml RNAse-A be-
fore being analyzed with LSRII (Becton Dickinson). Ana-
lysis of flow cytometry data was conducted with DIVA
software.
Construction and analysis of pGEMT-Myc-tax clones
Forty-eight hours after infection with the Tax pseu-
dotyped virus, the genomic DNA was isolated from the
pUMycProm transgenic cells and subjected to PCR to
amplify the ccpeMYC promoter region (556 bp). The
PCR product was extracted from the gel (Qiagen kit)
and cloned into the pGEM-T Easy vector using the manu-
facturer’s recommendations (Promega) and sequenced.
DNA combing
DNA combing was performed essentially as described [4],
with slight modifications. Briefly, 4.105 cells were seeded
for 48 h. Induction of Tax expression was done by adding
CdCl2 (20 μM, 36 h). Before harvesting, cells were labelled
by two successive pulses of IdU (25 μM, 15 min, MP
Biomedicals) and CldU (200 μM, 15 min, MP Biomedi-
cals). DNA fibers were extracted in agarose plugs contai-
ning 8.104 cells, immediately after IdU and CldU labelling
and were stretched on silanized coverslips. IdU and CldU
were detected with a mouse antibody (347580; Becton
Dickinson; 1/20) and a secondary antibody coupled to
Alexa 546 (A21123, Molecular Probes; 1/50), and with a
rat monoclonal antibody (ABC117 7513, AbCys; 1/20)
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Molecular Probes; 1/50). DNA molecules were coun-
terstained with an anti-ssDNA antibody (MAB3034,
Chemicon; 1/500) and an anti-mouse IgG coupled to
Alexa 647 (A21241, Molecular Probes, 1/50). DNA fibers
were analyzed on a Leica DM6000B microscope equipped
with a CoolSNAP HQ1 4 CCD camera, with 490, 550 and
650 nm filters (Montpellier RIO Imaging facility of IGH).
Data acquisition was performed with MetaMorph (Roper
Scientifics). Representative images of DNA fibers were as-
sembled from different fields of view and were processed
as described [4].
Graphs and statistical analysis
Box-and-whisker graphs were plotted with Prism v5.0
(GraphPad Software). For all graphs, the top and bottom
of the box corresponds to the 25th and 75th percentile
(the lower and upper quartiles, respectively) and the line
near the middle of the box marks the median (50th
percentile).Whiskers correspond to the 5–95 percentiles.
Data not included between the whiskers are plotted as
outliers (dots). Statistical analysis was performed in
Prismv5.0 (GraphPad Software) using the non-parametric
Mann–Whitney rank sum test.
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